SEC Info - Elanco Animal Health Inc.

SEC Info℠

Home

Help

Please Sign In

Elanco Animal Health Inc. – ‘8-K’ for 1/31/23

On: Tuesday, 1/31/23, at 4:05pm ET · For: 1/31/23 · Accession #: 1104659-23-8591 · File #: 1-38661

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/23  Elanco Animal Health Inc.         8-K:8       1/31/23   11:233K                                   Toppan Merrill/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 6: R1          Cover                                               HTML     50K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- tm234667d1_8k_htm                   XML     19K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.DEF  XBRL Definitions -- elan-20230131_def                XML     74K 
 4: EX-101.LAB  XBRL Labels -- elan-20230131_lab                     XML    105K 
 5: EX-101.PRE  XBRL Presentations -- elan-20230131_pre              XML     71K 
 2: EX-101.SCH  XBRL Schema -- elan-20230131                         XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               27±    36K 
11: ZIP         XBRL Zipped Folder -- 0001104659-23-008591-xbrl      Zip     20K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C: C: C: C:

i 0001739104 i false 0001739104 2023-01-31 2023-01-31 0001739104 us-gaap:CommonStockMember 2023-01-31 2023-01-31 0001739104 elan:TangiblePercentEquityUnitsMember 2023-01-31 2023-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): i January 31, 2023

i Elanco Animal Health Incorporated

(Exact name of registrant as specified in its charter)

i Indiana

i 001-38661

i 82-5497352

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(I.R.S. Employer

Identification No.)

i 2500 Innovation Way

i Greenfield, i Indiana

(Address of principal executive offices)

i 46140

(Zip Code)

Registrant’s telephone number, including area code: ( i 877) i 352-6261

Not Applicable

(Former Name or Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common stock, no par value	i ELAN	i New York Stock Exchange
i 5.00% Tangible Equity Units	i ELAT	i New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

i ¨ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01

Other Events.

On January 31, 2022, Elanco Animal Health Incorporated (“Elanco”) announced the settlement rate for the prepaid stock purchase contracts that are components of its outstanding 5.00% Tangible Equity Units (the “Units”) issued in January 2020. On February 1, 2023, holders will receive 1.5625 shares of Elanco’s common stock, no par value per share (the “Common Stock”), for each prepaid stock purchase contract that they hold, with cash to be paid in lieu of any fractional shares. Accordingly, upon settlement of all outstanding prepaid stock purchase contracts, Elanco expects to issue an aggregate of approximately 17.2 million shares of Common Stock. On February 1, 2023, Elanco will also make the final installment payment on the amortizing notes that are the other component of the Units. The Units will then cease to be outstanding.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Elanco Animal Health Incorporated

Date: January 31, 2023	By:	/s/ Todd Young
		Name: Todd Young
		Title: Executive Vice President and Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

	2/1/23
Filed on / For Period end:	1/31/23
	1/31/22	4
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/19/23  Elanco Animal Health Inc.         S-8         5/19/23    4:95K                                    Toppan Merrill/FA

↑Top

Filing Submission 0001104659-23-008591 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)